<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">
Skip to content
Request a demo
March 20, 2019

SCRS Welcomes 4G Clinical to Global Impact Partner Program

March 14, 2019

SCRS Welcomes 4G Clinical to Global Impact Partner Program - Collaboration Aims to Include Site Voice in Clinical Trial Technology

ELLICOTT CITY, Md., March 14, 2019 /PRNewswire/ --The Society for Clinical Research Sites (SCRS) and 4G Clinical today announced 4G Clinical has joined the organization as a Global Impact Partner (GIP). SCRS' GIP Program provides a unique opportunity for sponsors, CROs and solution providers to engage with SCRS and its members in an impactful manner.

"Becoming a GIP demonstrates 4G Clinical's commitment to site sustainability by working directly with sites to solve operational challenges stemming from technology limitations, which ultimately impacts the entire industry," said Sean Soth, VP of global business partnerships at SCRS. "We are excited for this collaboration with 4G Clinical and believe it will have a meaningful impact on streamlining clinical trial execution."

"Clinical research sites are the ultimate end-users of the RTSM. And yet, traditionally they are not asked for input into the design of the system," says Neta Bendelac, Senior Director of strategy at 4G Clinical. "We believe the sites should have a voice in clinical research technology so they can spend more time with their patients and less time contacting help desks."

About SCRS 
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.

About 4G Clinical 
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. Learn more about 4G Clinical at www.4gclinical.com.

Tag(s): Press Releases

Amy Ripston

Related Blog Posts Headline

View All Blog Posts